Clarification of Optimal Anticoagulation Through Genetics

Clinical trial NCT00839657 · COMPLETED

Trial details

NCT number: NCT00839657
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Stroke Venous Thrombosis Atrial Fibrillation Atrial Flutter

Start date: 2009-09-01
Primary completion: 2013-04-01
Enrollment: 1015

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.